# Evaluation of the Truenat™MTB Plus/COVID-19 Test for TB (Tuberculosis) and COVID-19 (SARS-CoV2)

> **NCT05405296** · — · UNKNOWN · sponsor: **Foundation for Innovative New Diagnostics, Switzerland** · enrollment: 1480 (estimated)

## Conditions studied

- TB
- COVID-19

## Interventions

- **DEVICE:** Truenat™ MTB Plus/COVID-19

## Key facts

- **NCT ID:** NCT05405296
- **Lead sponsor:** Foundation for Innovative New Diagnostics, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-30
- **Primary completion:** 2024-04
- **Final completion:** 2024-09
- **Target enrollment:** 1480 (ESTIMATED)
- **Last updated:** 2024-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05405296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05405296, "Evaluation of the Truenat™MTB Plus/COVID-19 Test for TB (Tuberculosis) and COVID-19 (SARS-CoV2)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05405296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*